Reduced Overall Survival in Refractory MM Although the application of the first IMiD, lenalidomide, had significantly increased median overall survival (OS) 2 , Prof. Leleu commented that the treatment success was hindered by the refractoriness of M...

Background of the Patient The patient was a 53-year-old female with good health record. In 2010, the patient presented with some bone pain and proteinuria (2.5 g/day). However, evaluation on albumin level did not indicate renal impairment. Dr. Hwang...

Therapeutic Sequencing Strategy in Multiple Myeloma Date: 24 th June 2021 (Thursday) Time: 19:00 - 20:40 (GMT+8, HKT) Meeting format: Zoom meeting Address: Salon Room III, Hyatt Regency Hong Kong, 18 Hanoi Road, Tsim Sha Tsui, Kowloon The survival o...

Breast cancer ranks the first place among female cancers in Hong Kong, with the incidence increased nearly 4 times within the past 25 years. Although a wide spectrum of therapies for breast cancer is currently available, the prognosis of the disease...

The Potential and Challenge of Gene-edited Cellular Therapies The recent advances in genome editing allow precise manipulation of cellular DNA sequences and have raised hopes of curing serious genetic diseases. CRISPR-Cas9 is a specific and efficien...

Nutrition Intervention for Improving Health Outcomes of Cancer Patients Malnutrition is prevalent among cancer patients, whereas up to 70% of patients are at risk. The condition can adversely affect treatment outcomes, quality of life and survival 1...

Over the past 25 years, significant progress has been made in the treatment of multiple myeloma (MM) as reflected by the improved overall survival (OS). However, in relapsed and refractory MM (RRMM), median OS decreases with each extra line of thera...

The Live Symposium on Breast Health Education 2021 Breast cancer is the most common cancer among women both globally and locally, whereas the number of locally diagnosed female breast cancer cases has increased by 4 times from 1993 to 2018. This ind...

Standard Treatment Regimens for NSCLC and the Potential Challenges “Treatment goals vary across NSCLC patients at different stages of the disease. For patients at early and intermediate stages of NSCLC, they are usually treated with curative i...

T he Importance of Achieving Deepest Possible Response and Continuous Therapy While improving long-term survival for patients with MM is desirable, clinical data suggested that complete response (CR) to treatment is associated with survival outcomes...

Uncovering Psychological Burden of Advanced Prostate Cancer Psychological distress is prevalent among patients with advanced PCa as compared to those with localised disease, and the morbidity adversely affects patients’ HRQOL 4 . Essentially, ...

Breast cancer is one of the prevalent malignancies among females in Hong Kong. To investigate the potential impacts of regular screening on disease diagnosis and mortality, a randomised controlled trial recruited 151, 538 women aged 35-64 with no hi...